Market revenue in 2022 | USD 29.0 million |
Market revenue in 2030 | USD 65.8 million |
Growth rate | 10.8% (CAGR from 2022 to 2030) |
Largest segment | 13-24 weeks |
Fastest growing segment | 0-12 weeks |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | 0-12 weeks, 13-24 weeks, 25-36 weeks |
Key market players worldwide | CooperSurgical, Natera Inc, Eurofins Scientific SE, Illumina Inc, Centogene NV Ordinary Shares, MedGenome, Myriad Genetics Inc, Roche Holding AG, Qiagen NV, Labcorp Holdings Inc, Quest Diagnostics Inc, Biora Therapeutics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non invasive prenatal testing market will help companies and investors design strategic landscapes.
13-24 weeks was the largest segment with a revenue share of 52.07% in 2022. Horizon Databook has segmented the South Africa non invasive prenatal testing market based on 0-12 weeks, 13-24 weeks, 25-36 weeks covering the revenue growth of each sub-segment from 2018 to 2030.
The government of South Africa has made improvements in basic healthcare reforms by providing free primary healthcare and diagnostic services to children & pregnant ladies. It has collaborated with the United Nations Organization to improve healthcare measures toward decreasing mortality and increasing life expectancy.
There are only a few companies in South Africa's non-invasive prenatal testing market. homeDNAdirect and EasyDNA provide genetic testing and non-invasive prenatal services in the country. Ampath Laboratories provides IONA NIPT in South Africa.
This high prevalence along with the launch of novel products in the region is expected to drive the market over the forecast period. Despite high prevalence of Down syndrome, South Africa non-invasive prenatal testing market is expected to witness stagnant growth. This stagnant growth can be attributed to low awareness, weak reimbursement policies, lack of access to healthcare, and low affordability of costly tests in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa non invasive prenatal testing market , including forecasts for subscribers. This country databook contains high-level insights into South Africa non invasive prenatal testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account